Safety of beta‐nicotinamide mononucleotide (β‐NMN) pursuant the regulation (EU) 2015/2283 and the bioavailability of nicotinamide from this source in the context of Directive 2002/46/EC.

Saved in:
Bibliographic Details
Title: Safety of beta‐nicotinamide mononucleotide (β‐NMN) pursuant the regulation (EU) 2015/2283 and the bioavailability of nicotinamide from this source in the context of Directive 2002/46/EC.
Authors: Turck, Dominique (AUTHOR), Bohn, Torsten (AUTHOR), Cámara, Montaña (AUTHOR), Castenmiller, Jacqueline (AUTHOR), De Henauw, Stefaan (AUTHOR), Jos, Ángeles (AUTHOR), Maciuk, Alexandre (AUTHOR), Mangelsdorf, Inge (AUTHOR), McNulty, Breige (AUTHOR), Naska, Androniki (AUTHOR), Pentieva, Kristina (AUTHOR), Siani, Alfonso (AUTHOR), Thies, Frank (AUTHOR), Aguilera‐Gómez, Margarita (AUTHOR), Cubadda, Francesco (AUTHOR), Frenzel, Thomas (AUTHOR), Gundert‐Remy, Ursula (AUTHOR), Marcon, Francesca (AUTHOR), McArdle, Harry J. (AUTHOR), Neuhäuser‐Berthold, Monika (AUTHOR)
Source: EFSA Journal. May2026, Vol. 24 Issue 5, p1-19. 19p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:18314732
DOI:10.2903/j.efsa.2026.10007